Integrating conventional mesothelioma therapies with immuno- and gene-therapies
Integrating conventional mesothelioma therapies with immuno- and gene-therapies
批准号:
nhmrc : 458533
负责人:
Bernadette Scott
金额:
$53.67万
依托单位国家:
澳大利亚
项目类别:
NHMRC Strategic Awards
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31
中文摘要
石棉引起的癌症是医学上已知的最具侵袭性的癌症之一。不幸的是,治疗并不是非常有效,这些癌症特别是间皮瘤很少被治愈。由于最近的科学研究表明,包括免疫疗法在内的治疗组合可以有效,即旨在刺激身体抗癌免疫反应攻击癌症的治疗,我们计划开展这项工作,以准确确定哪些组合可能是最有效的,因此最适合在患者身上进行临床试验。
英文摘要
Asbestos-induces cancers are some of the most aggressive cancers know to medicine. Unfortunately, treatments are not very effective and it is unusual for these cancers to be cured, particularly mesothelioma. Because recent scientific studies have suggested that combinations of therapy which include immunotherapy, ie treatments aimed at stimulating the bodies anti-cancer immune responses to attack the cancer, can be effective, we plan to develop this work in order to determine exactly which combinations are likely to be the most effective and therefore the most suitable for clinical trial in patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunoregulatory T cells and Tumour Immunity
-
批准号:nhmrc : 143622
-
项目类别:NHMRC Project Grants
-
资助金额:$14.14万
-
财政年份:2001
-
负责人:Bernadette Scott
-
依托单位:
Role of CD4 T cells and APCs in the induction and maintenance of an effective antitumor response
-
批准号:nhmrc : 143674
-
项目类别:NHMRC Project Grants
-
资助金额:$30.21万
-
财政年份:2001
-
负责人:Bernadette Scott
-
依托单位:
海外基金